Researchers in Japan uncover the mechanism by which AP2A1 modulates senescence, rejuvenation and cellular aging.
A team of scientists at Osaka University has identified a molecular mechanism that allows aging cells to regain youthful characteristics. The study, published in Cellular Signalling, demonstrates that AP2A1, a protein associated with intracellular transport, plays a key role in maintaining the enlarged structure of senescent cells; when its expression is suppressed, aged cells exhibit features of rejuvenation [1].
The role of AP2A1 in cellular aging
Cellular senescence is a state in which cells cease dividing and accumulate with age, contributing to various age-related conditions. Senescent cells tend to increase in size due to alterations in their cytoskeleton and adhesion properties, and they display a reorganized structure of stress fibers, which are essential cellular components that facilitate movement and environmental interaction.
“We still don’t understand how these senescent cells can maintain their huge size,” says lead author of the study Pirawan Chantachotikul. “One intriguing clue is that stress fibers are much thicker in senescent cells than in young cells, suggesting that proteins within these fibers help support their size [2].”
Longevity.Technology: The discovery that AP2A1 modulates cellular senescence and rejuvenation opens a compelling, yet complex, path for therapeutic intervention. If targeting this protein can restore cell morphology, reduce stress fiber thickening and enhance motility, it presents a potential strategy for mitigating cellular dysfunction in age-related diseases. However, its role in integrin β1 translocation raises concerns about unintended consequences – could altering adhesion dynamics disrupt tissue integrity or affect wound healing? Senescence is a double-edged sword, preventing malignancy while contributing to tissue dysfunction; AP2A1’s modulation may hold promise for regenerative medicine but demands careful evaluation to avoid triggering uncontrolled proliferation. The challenge lies in translating these findings into safe, precise interventions that restore cellular function without compromising homeostasis – a fine balance that will determine the viability of AP2A1-based therapies.
The researchers found that AP2A1 is significantly upregulated in senescent human fibroblasts, where it localizes along thickened stress fibers and facilitates integrin β1 translocation, reinforcing the attachment of these enlarged cells to their substrate.
The researchers also found that AP2A1 interacts closely with integrin β1, a protein that helps cells anchor themselves to the collagen framework surrounding them. Both proteins travel along stress fibers, strengthening the connection between senescent cells and their environment; this increased adhesion may explain why aging cells develop thickened, raised structures. By reinforcing these attachments, AP2A1 and integrin β1 could help stabilize senescent cells within tissues, potentially contributing to their accumulation over time.
Given that AP2A1 expression is so closely linked to signs of aging in senescent cells, it could potentially serve as a biomarker for cellular aging – its upregulation across different pathways of senescence suggests it may be a reliable indicator of cellular age and physiological changes associated with senescence.
Experimental evidence of rejuvenation
Through a series of experiments, the team demonstrated that reducing AP2A1 levels reversed many features of cellular aging: cells became smaller, exhibited reduced senescence markers such as p53 and p21 and regained a more dynamic cytoskeletal structure. Conversely, overexpression of AP2A1 in young cells induced premature senescence, indicating its pivotal role in modulating cell fate [1].
“The results were very intriguing,” explains Shinji Deguchi, senior author. “Suppressing AP2A1 in older cells reversed senescence and promoted cellular rejuvenation, while AP2A1 overexpression in young cells advanced senescence [2].”
The study used multiple models of cellular senescence, including replicative aging, ultraviolet radiation and drug-induced stress, confirming that AP2A1 expression consistently increases across different pathways of senescence. Knockdown of AP2A1 not only altered cell morphology but also enhanced cellular proliferation and motility, key indicators of rejuvenation.
“Our findings suggest that senescent cells maintain their large size through improved adhesion to the extracellular matrix via AP2A1 and integrin β1 movement along enlarged stress fibers,” concludes Chantachotikul [2].
Navigating the cellular crossroads
The accumulation of senescent cells is implicated in several age-related diseases, including cardiovascular disease, neurodegenerative conditions and metabolic disorders. While senolytic drugs aim to eliminate these cells, an alternative or complementary approach could involve reprogramming them toward a more youthful state.
While the findings are promising, further research is required to explore how AP2A1 modulation translates to complex biological systems beyond cell culture. Investigating its role in different tissue types and in vivo models will be crucial in assessing the feasibility of potential interventions.
The identification of AP2A1 as a key regulator of cell fate opens new possibilities in the study of aging and regenerative medicine. Whether through gene therapy, pharmacological inhibitors or other means of modulating AP2A1 activity, this research provides an interesting foundation for future studies aimed at mitigating the impact of cellular senescence.
[1] http://dx.doi.org/10.1016/j.cellsig.2025.111616
[2] https://resou.osaka-u.ac.jp/en/research/2025/20250207_1
